Advances in the pharmacological control of the bladder

Experimental Physiology

Volumn 84, Issue 1, 1999, Pages 195-213

  Andersson, Karl Erik ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; DARIFENACIN; FLURBIPROFEN; FORSKOLIN; MUSCARINIC RECEPTOR BLOCKING AGENT; PINACIDIL; POTASSIUM CHANNEL STIMULATING AGENT; PROSTANOID; RESINIFERATOXIN; TACHYKININ; TOLTERODINE; VAMICAMIDE; VINPOCETINE;

BLADDER; BLADDER FUNCTION; CONFERENCE PAPER; CONSTIPATION; HUMAN; MICTURITION DISORDER; XEROSTOMIA;

EID: 0032942662     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-445X.1999.tb00083.x     Document Type: Conference Paper

References (138)

1. 3H-acetylcholine secretion in the guinea pig urinary bladder in vitro. Journal of Pharmacology and Experimental Therapeutics 4, 458-468.
2. ÅMARK, P. & NERGÅRDH, A. (1991). Influence of adrenergic agonists and antagonists on urethral pressure, bladder pressure and detrusor hyperactivity in children with myelodysplasia. Acta Paediatrica Scandinavica 80, 824-832.
3. ÅMARK, P., NERGÅRDH, A. & KINN, A. C. (1986). The effect of noradrenaline on the contractile response of the urinary bladder. Scandinavian Journal of Urology and Nephrology 20, 203-207.
4. ANDERSSON, K.-E. (1986). Clinical relevance of some findings in neuro-anatomy and neurophysiology of the lower urinary tract. Clinical Science 70, suppl. 14, 21-32.
5. ANDERSSON, K.-E. (1988). Current concepts in the treatment of disorders of micturition. Drugs 35, 477-494.
6. ANDERSSON, K.-E. (1992). Clinical pharmacology of potassium channel openers. Pharmacology and Toxicology 70, 244-254.
7. ANDERSSON, K.-E. (1993). The pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacological Reviews 45, 253-308.
8. ANDERSSON, K.-E. (1997). The overactive bladder: pharmacologic basis of drug treatment. Urology 50, suppl. 6A, 74-84.
9. ANDERSSON, K.-E. (1998). The importance of the cholinergic system in neuro-urology. European Urology (in the Press).
10. ANDERSSON, K.-E., FOVAEUS, M., MORGAN, E. & MCLORIE, G. (1986). Comparative effects of five different calcium channel blockers on the atropine resistant contraction in electrically stimulated rabbit urinary bladder. Neurourology and Urodynamics 5, 579-586.
11. APPELL, R. A. (1997). Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology 50, suppl. 6A, 90-96.
12. AVELINO, A., CRUZ, F. & COIMBRA, A. (1998). Lidocaine prevents noxious excitation of bladder afferents induced by intravesical capsaicin without interfering with the ensuing sensory desensitization: an experimental study in the rat. Journal of Urology 159, 567-570.
13. BARRAS, M., VAN DER GRAF, P. H., CHRISTOPHE, P. & ITZCHAK, A. (1996). Relaxant efficacy of potassium channel openers in rabbit isolated bladder and mesenteric artery. European Journal of Urology 30, suppl. 2, 240 (abstract 894).
14. BEAVO, J. A. (1995). Cyclic nucleotide phosphodiesterases: functional implications of mutiple isoforms. Physiological Reviews 75, 725-748.
15. BO, X. & BURNSTOCK, G. (1990). The effects of BAY K 8644 and nifedipine on the responses of rat urinary bladder to electrical field stimulation, β-γ-methylene ATP and acetylcholine. British Journal of Pharmacology 101, 494-498.
16. BORS, E. & COMARR, A. E. (1971). Physiology of micturition, its neurological disorders and sequelae. In Neurourological Urology. University Park Press, Baltimore.
17. BRADING, A. F. (1998). A myogenic basis for the overactive bladder. Urology 50, suppl. 6A, 57-67.
18. CAINE, M. (1986). The present role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia. Journal of Urology 136, 1-4.
19. CARDOZO, L. D., STANTON, S. L., ROBINSON, H. & HOLE, D. (1980). Evaluation on flurbiprofen in detrusor instability. British Medical Journal 280, 281-282.
20. 2+ signalling in cultured smooth muscle cells from human bladder. Experimental Physiology 81, 553-564.
21. CHANDIRAMANI, V. A., PETERSON, T., DUTHIE, G. S. & FOWLER, C. J. (1996). Urodynamic changes during therapeutic intravesical instillations of capsaicin. British Journal of Urology 77, 792-797.
22. CRAFT, R. M., COHEN, S. M. & PORRECA, F. (1995). Long-lasting desensitization of bladder afferents following intravesical resiniferatoxin and capsaicin in the rat. Pain 61, 317-323.
23. CRUZ, F., AVELINO, A. & COIMBRA, A. (1996). Desensitization follows excitation of bladder primary afferents by intravesical capsaicin, as shown by c-fos activation in the spinal cord. Pain 64, 553-557.
24. CRUZ, F., GUIMARAES, M., SILVA, C. & REIS, M. (1997a). Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet 350, 640-631.
25. CRUZ, F., GUIMARAES, M., SILVA, C., RIO, M. E., COIMBRA, A. & REIS, M. (1997b). Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. Journal of Urology 157, 585-589.
26. 3H]-acetylcholine release in the rat isolated urinary bladder. Journal of Pharmacology and Experimental Therapeutics 283, 750-756.
27. DAMASER, M. S., KIM, K.-B., LONGHURST, P. A., WEIN, A. J. & LEVIN, R. M. (1997). Calcium regulation of urinary bladder function. Journal of Urology 157, 732-738.
28. DE GROAT, W. C. (1997). A neurologic basis for the overactive bladder. Urology 50, suppl. 6A, 36.52.
29. DE GROAT, W. C., BOOTH, A. M. & YOSHIMURA, N. (1993). Neurophysiology of micturition and its modification in animal models of human disease. In The Autonomic Nervous System, vol. 6, Nervous Control of the Urogenital System, chap. 8, ed. MAGGI, C. A., pp. 227-289. Harwood Academic Publishers, London, UK.
30. DE RIDDER, D., CHANDIRAMANI, V., DASGUPTA, P., VAN POPPEL, H., BAERT, L. & FOWLER, C. J. (1997). Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. Journal of Urology 158, 2087-2092.
31. EATON, A. C. & BATES, C. P. (1982). An in vitro physiological study of normal and unstable human detrusor muscle. British Journal of Urology 54, 653-657.
32. EDWARDS, G., HENSHAW, M., MILLER, M. & WESTON, A. H. (1991). Comparison of the effects of several potassium channel openers on rat bladder and rat portal vein in vitro. British Journal of Pharmacology 102, 679-686.
33. EGLEN, R. M., HEGDE, S. S. & WATSON, N. (1996). Muscarinic receptor subtypes and smooth muscle function. Pharmacological Reviews 48, 531-565.
34. FORMAN, A., ANDERSSON, K.-E., HENRIKSSON, L., RUD, T. & ULMSTEN, U. (1978). Effects of nifedipine on the smooth muscle of the human urinary tract in vitro and in vivo. Acta Pharmacologica and Toxicologica 43, 111-118.
35. FOWLER, C. J., JEWKES, D., MCDONALD, W. I., LYNN, B. & DE GROAT, W. C. (1992). Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 339, 1239.
36. GALLEGOS, C. R. & FRY, C. H. (1994). Alterations to the electrophysiology of isolated human detrusor smooth muscle cells in bladder disease. Journal of Urology 151, 754-758.
37. GARY, T. & ROBERTSON, D. (1994). Lessons learned from dopamine β-hydroxylase deficiency in humans. News in Physiological Sciences 9, 35-39.
38. GEIRSSON, G., FALL, M. & LINDSTRÖM, S. (1993). Subtypes of overactive bladder in old age. Age and Aging 22, 125-131.
39. GEIRSSON, G., FALL, M. & SULLIVAN, L. (1995). Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hypereflexia. Journal of Urology 154, 1825-1829.
40. GERMAN, K., BEDWANI, J., DAVIES, J., BRADING, A. F. & STEPHENSON, T. P. (1995). Physiological and morphometric studies into the pathophysiology of detrusor hyperrflexia in neuropathic patients. Journal of Urology 153, 1678-1683.
41. GILMORE, N. J. & VANE, J. R. (1971). Hormones released into the circulation when the urinary bladder of anaesthetized dog is distended. Clinical Science 41, 69-83.
42. GIULIANI, S., PATACCHINI, R., BARBANTI, G., TURINI, D., ROVERO, P., QUARTARA, L., GIACHETTI, A. & MAGGI, C. A. (1993). Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors. Journal of Pharmacology and Experimental Therapeutics 267, 590-595.
43. GOEPEL, M., WITTMANN, A., RÜBBEN, H. & MICHEL, M. C. (1997). Comparison of adrenoceptor subtype expression in porcine and human bladder and prostate. Urological Research 25, 199-206.
44. GOSLING, J. A., GILPIN, S. A., DIXON, J. S. & GILPIN, C. J. (1986). Decrease in the autonomic innervation of human detrusor muscle in outflow obstruction. Journal of Urology 136, 501-504.
45. HARRISON, S. C. V., HUNNAM, G. R., FARMAN, P. & DOYLE, P. T. (1987). Bladder instability and denervation in patients with bladder outflow obstruction. British Journal of Urology 60, 519-522.
46. 3-receptors coupled to inositol phospholipid hydrolysis in human detrusor cultured smooth muscle cells. Journal of Urology 154, 1241-1245.
47. HASHITANI, H., SUZUKI, H. & KUMAZAWA, J. (1996). Effects of Y26763, a novel K-channel opener, on electrical responses of smooth muscle in the guinea-pig bladder. Journal of Urology 155, 1454-1458.
48. HEDLUND, H., ANDERSSON, K.-E. & MATTIASSON, A. (1991). Effects of pinacidil on detrusor instability in men with outlet obstruction. Journal of Urology 146, 1345-1347.
49. 3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. British Journal of Pharmacology 120, 1409-1418.
50. HOMMA, Y., ASO, Y., KAWABE, K., KUMAMOTO, Y., TSUCHIDA, M., NISHIZAWA, O., SHIMAZAKI, J., YASUDA, K., KURITA, T., KUMAZAWA, J., YAMASHITA, H., KURIYAMA, K. & STUDY GROUP (1997). Randomized double-blind study to compare clinical efficacy of temiverine and propiverine for unstable bladder and detrusor hyperreflexia. Neurourology and Urodynamics 16, 345-346.
51. HOWE, B. B., HALTERMAN, T. J., YOCHIM, C., DO, M. L., PETTINGER, S. J., STOW, R. B., OHNMACHT, C. J., RUSSEL, K., EMPFIELD, J. R., TRAINOR, D. A., BROWN, F. J. & KAU, S. T. (1995). Zeneca ZD6169: A novel KATP channel opener with in vivo selectivity for urinary bladder. Journal of Pharmacology and Experimental Therapeutics 274, 884-890.
52. IGAWA, Y., NISHIZAWA, O., YAMAZAKI, Y., TAKEDA, H., HAYAKAWA, K., AKAHANE, M. & AJISAWA, Y. (1997). Functional and molecular biological evidence of β-adrenoceptors in the human detrusor. Journal of Urology 157, 175 (abstract 677).
53. ISHIZUKA, O., MATTIASSON, A. & ANDERSSON, K.-E. (1995a). Urodynamic effects of intravesical resiniferatoxin and capsaicin in conscious rats with and without outflow obstruction. Journal of Urology 154, 611-616.
54. ISHIZUKA, O., MATTIASSON, A. & ANDERSSON, K.-E. (1995b).Tachykinin effects on bladder activity in conscious, normal rats. Journal of Urology 154, 257-261.
55. JENSEN, D. (1981). Uninhibited neurogenic bladder treated with prazosin. Scandinavian Journal of Urology and Nephrology 15, 299-233.
56. JEREMY, J. Y., TSANG, V., MIKHAILIDIS, D. P., ROGERS, H., MORGAN, R. J. & DANDONA, P. (1987). Eicosanoid synthesis by human urinary bladder mucosa: pathological implications. British Journal of Urology 59, 36-39.
57. JIANG, W., KIBBLE, A. & MORRISON, J. F. B. (1995). The effect of capsaicin on pelvic afferent inputs from the urinary bladder of anaesthetized rats. Journal of Physiology 487.P, 119P.
58. KINDER, R. B. & MUNDY, A. R. (1987). Pathophysiology of idiopathic detrusor instability and detrusor hyperreflexia. An in vitro study of human detrusor muscle. British Journal of Urology 60, 509-515.
59. KOMERSOVA, K., ROGERSON, J. W., CONWAY, E. L., LIM, T. C., BROWN, D. J., KRUM, H., JACKMAN, G. P., MURDOCH, R. & LOUIS, W. J. (1995). The effect of levcromakalim (BRL 38227) on bladder function in patients with high spinal cord lesions. British Journal of Clinical Pharmacology 39, 207-209.
60. KUO, H.-C. (1997). Inhibitory effect of capsaicin on detrusor contractility: Further study in the presence of ganglionic blocker and neurokinin receptor antagonist in the rat urinary bladder. Urologia Internationalis 59, 95-101.
61. LARSEN, J. J. (1979). α-and β-Adrenoceptors in the detrusor muscle and bladder base of the pig and β-adrenoceptors in the detrusor of man. British Journal of Urology 65, 215-222.
62. LAURENZA, A., MCHUGH-SUTKOWSKI, E. M. & SEAMON, K. B. (1989). Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action. Trends in Pharmacological Sciences 10, 442-447.
63. LAURENZA, A., ROBBINS, J. D. & SEAMON, K. B. (1992). Interaction of aminoalkylcarbamates of forskolin with adenylyl cyclase: synthesis of an iodinated derivative of forskolin with high affinity for adenylyl cyclase. Molecular Pharmacology 41, 360-368.
64. LAZZERI, M., BENEFORTI, P. & TURINI, D. (1997). Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor. Journal of Urology 158, 2093-2096.
65. LEVIN, R. M., HAYES, L., ZHAO, Y. & WEIN, A. J. (1992). Effect of pinacidil on spontaneous and evoked contractile activity. Pharmacology 45, 1-8.
66. LEVIN, R. M., RUGGIERI, M. R. & WEIN, A. J. (1988). Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding. Journal of Urology 139, 844-848.
67. LEVIN, R. M. & WEIN, A. J. (1979). Quantitative analysis of alpha and beta adrenergic receptor densities in the lower urinary tract of the dog and the rabbit. Investigative Urolology 17, 75-77.
68. LI, J. H., YASAY, G. D., ZOGRAFOS, P., KAU, S. T., OHNMACHT, C. J., RUSSELL, K., EMPFIELD, J. R., BROWN, F. J., TRAINOR, D. A., BONEV, A. D., HEPPNER, T. J. & NELSON, M. T. (1995). Zeneca ZD6169 and its analogs from a novel series of anilide tertiary carbinols: In vitro KATP channel opening activity in bladder detrusor. Pharmacology 52, 33-42.
69. LINCOLN, J. & BURNSTOCK, G. (1993). Autonomic innervation of the urinary bladder and urethra. In The Autonomic Nervous System, vol. 6, Nervous Control of the Urogenital System, chap. 8, ed. MAGGI, C. A., pp. 33-68. Harwood Academic Publishers, London, UK.
70. 3-adrenoceptors. British Journal of Clinical Pharmacology 43, 291-300.
71. LONGHURST, P. A., LEGGETT, R. E. & BRISCOE, J. A. K. (1995). Characterization of the functional muscarinic receptors in the rat urinary bladder. British Journal of Pharmacology 116, 2279-2285.
72. sα. Biochemistry 33, 12852-12859.
73. MAGGI, C. A. (1992). Prostanoids as local modulators of reflex micturition. Pharmacological Research 25, 13-20.
74. MAGGI, C. A. (1993). The dual, sensory and 'efferent' function of the capsaicin-sensitive primary sensory neurons in the urinary bladder and urethra. In The Autonomic Nervous System, vol. 6, Nervous Control of the Urogenital System, chap. 11, ed. MAGGI, C. A., pp. 383-422. Harwood Academic Publishers, London.
75. MAGGI, C. A. (1995a). Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Progress in Neurobiology 45, 1-98.
76. MAGGI, C. A. (1995b). The mammalian tachykinin receptors. General Pharmacology 26, 911-944.
77. MAGGI, C. A., BARBANTI, G., SANTICIOLI, P., BENEFORTI, P., MISURI, D., MELI, A. & TURINI, D. (1989). Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. Journal of Urology 142, 150-154.
78. MALMGREN, A., ANDERSSON, K.-E., ANDERSSON, P.-O., FOVAEUS, M. & SJÖGREN, C. (1990). Effects of cromakalim (BRL 34915) and pinacidil on normal and hypertrophied rat detrusor in vitro. Journal of Urology 143, 828-834.
79. MALMGREN, A., ANDERSSON, K.-E., SJÖGREN, C. & ANDERSSON, P.-O. (1989). Effects of pinacidil and cromakalim (BRL 34915) on bladder function in rats with detrusor instability. Journal of Urology 142, 1134-1138.
80. MARTIN, S. W., RADLEY, S. C., CHESS-WILLIAMS, R., KORSTANJE, C. & CHAPPLE, C. R. (1997). Relaxant effects of potassium-channel openers on normal and hyperreflexic detrusor muscle. British Journal of Urology 80, 405-413.
81. MASUDA, N., UCHIDA, W., SHIRAI, Y., SHIBASAKI, K., GOTO, K. & TAKENAKA, T. (1995). Effect of the potassium channel opener YM934 on the contractile response to electrical field stimulation in pig detrusor smooth muscle. Journal of Urology 154, 1914-1920.
82. MIKHAILIDIS, D. P., JEREMY, J. Y. & DANDONA, P. (1987). Urinary bladder prostanoids - their synthesis, function and possible role in the pathogenesis and treatment of disease. Journal of Urology 137, 577-582.
83. MILLS, I. W., GREENLAND, J. E., MCMURRAY, G., HO, K. M. T. & BRADING, A. F. (1997). Detrusor denervation in idiopathic instability. Neurourology and Urodynamics 15, 417-418.
84. MONTGOMERY, B. S. & FRY, C. H. (1992). The action potential and net membrane currents in isolated human detrusor smooth muscle cells. Journal of Urology 147, 176-184.
85. 2α on contractility and cAMP and cGMP contents in lower urinary tract smooth muscle. Urologia Internationalis 52, 200-203.
86. MOSTWIN, J. L. (1986). The action potential of guinea pig bladder smooth muscle. Journal of Urology 135, 1299-1303.
87. MULHALL, J. P., DALLER, M., TRAISH, A. M., GUPTA, S., PARK, K., SALIMPOUR, P., PAYTON, T. R., KRANE, R. J. & GOLDSTEIN, I. (1997). Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy. Journal of Urology 158, 1752-1758.
88. NERGÅRDH, A., BORÉUS, L. O. & NAGLO, A. S. (1977). Characterization of the adrenergic beta-receptors in the urinary bladder of man and cat. Acta Pharmacologica and Toxicologica 40, 14-21.
89. NEWGREEN, D. T., ANDERSON, C. W. P., CARTER, A. J. & NAYLOR, A. M. (1995). Darifenacin - a novel bladder-selective agent for the treatment of urge incontinence. Neurourology and Urodynamics 14, 95-96.
90. NILVEBRANT, L., ANDERSSON, K.-E., GILLBERG, P.-G., STAHL, M. & SPARF, B. (1997). Tolterodine - a new bladder selective antimuscarinic agent. European Journal of Pharmacology 327, 195-207.
91. NISHIMOTO, T., LATIFPOUR, J., WHEELER, M. A., YOSHIDA, M. & WEISS, R. M. (1995). Age-dependent alterations in β-adrenergic responsiveness of rat detrusor smooth muscle. Journal of Urology 153, 1701-1705.
92. PAIRET, M. & ENGELHARDT, G. (1996). Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundamental and Clinical Pharmacology 10, 1-17.
93. 2 receptors on isolated human urinary bladder, prostatic urethra and prostate. Journal of Pharmacology and Experimental Therapeutics 277, 700-705.
94. 2-stimulated bladder activity in conscious rats. Journal of Urology 158, 2300-2304.
95. PARK, J. M., YANG, T., AREND, L. J., SMART, A. M., SCHNERMANN, J. B. & BRIGGS, J. P. (1997). Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction. American Journal of Physiology 273, F538-544.
96. PERLBERG, S. & CAINE, M. (1982). Adrenergic response of bladder muscle in prostatic obstruction. Urology 20, 524-537.
97. PETERSEN, T., HUSTED, S. & SIDENIUS, P. (1989). Prazosin treatment of neurological patients with detrusor hyperreflexia and bladder emptying disability. Scandinavian Journal of Urology and Nephrology 23, 189-194.
98. POLSON, J. B. & STRADA, S. J. (1996). Cyclic nucleotide phosphodiesterases and vascular smooth muscle. Annual Review of Pharmacology and Toxicology 36, 403-427.
99. RESNICK, N. M., YALLA, S. W. & LAURINO, E. (1989). The pathophysiology of urinary incontinence among institutionalized elderly persons. New England Journal of Medicine 320, 1-7.
100. RESTORICK, J. M. & MUNDY, A. R. (1989). The density of cholinergic and alpha and beta adrenergic receptors in the normal and hyper-reflexic human detrusor. British Journal of Urology 63, 32-35.
101. SASAKI, Y., HAMADA, K., YAMAZAKI, C., SETO, T, KIMURA, Y., UKAI, Y., YOSHIKUNI, Y. & KIMURA, K. (1997). Effect of NS-21, an anticholinergic drug with calcium antagonistic activity, on lower urinary tract function in a rat model of urinary frequency. International Journal of Urology 4, 401-406.
102. 3 muscarinic receptors in the guinea pig colon. Journal of Pharmacology and Experimental Therapeutics 284, 269-277.
103. SHAPIRO, E., TANG, R., ROSENTHAL, E. & LEPOR, H. (1991). The binding and functional properties of voltage dependent calcium channel receptors in pediatric normal and myelodysplastic bladders. Journal of Urology 146, 520-523.
104. SIBLEY, G. N. A. (1987). The physiological response of the detrusor muscle to experimental bladder putflow obstruction in the pig. British Journal of Urology 60, 332-336.
105. SJÖGREN, C., ANDERSSON, K.-E., HUSTED, S., MATTIASSON, A. & MØLLER-MADSEN, B. (1982). Atropine resistance of the transmurally stimulated isolated human bladder. Journal of Urology 128, 1368-1371.
106. SMITH, D. J. & CHAPPLE, C. R. (1994). In vitro response of human bladder smooth muscle in unstable obstructed male bladders: a study of pathophysiological causes. Neurourology and Urodynamics 13, 414-415.
107. SMITH, P. H., COOK, J. B. & PRASAD, E. W. M. (1974). The effect of ubretid on bladder function after recent complete spinal cord injury. British Journal of Urology 46, 187-192.
108. SOMOGYI, G. T. & DE GROAT, W. C. (1992). Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladder. Journal of the Autonomic Nervous System 37, 89-98.
109. SOMOGYI, G. T., TANOWITZ, M. & DE GROAT, W. C. (1994). M1 muscarinic receptor-mediated facilitation of actylcholine release in the rat urinary bladder. Journal of Physiology 480, 81-89.
110. SPEAKMAN, M. J., BRADING, A. F., GILPIN, C. J., DIXON, J. S., GILPIN, S. A. & GOSLING, J. A. (1987). Bladder outflow obstruction - a cause of denervation supersensitivity. Journal of Urology 138, 1461-1466.
111. STEERS, W. D. & DE GROAT, W. C. (1988). Effect of bladder outlet obstruction on micturition reflex pathways in the rat. Journal of Urology 140, 864-871.
112. STROSBERG, D. & PIETRI-ROUXEL, F. (1997). Function and regulation of the β3-adrenoceptor. Trends in Pharmacological Sciences 17, 273-381.
113. SUNDIN, T. & DAHLSTRÖM, A. (1973). The sympathetic innervation of the urinary bladder and urethra in the normal state and after parasympathetic denervation at the spinal root level. An experimental study in cats. Scandinavian Journal of Urology and Nephrology 7, 131-149.
114. SZALLASI, A. (1994). The vanilloid (Capsaicin) receptor: receptor types and species differences. General Pharmacology 25, 223-243.
115. 3-receptor subtypes in the detrusor of human urinary bladder -Evaluation by mRNA expression and isometric contraction. Neurourology and Urodynamics 16, 365-366.
116. TRIVEDI, S., POTTER-LEE, L., LI, J. H., YASAY, G. D., RUSSELL, K., OHNMACHT, C. J., EMPFIELD, J. R., TRAINOR, D. A. & KAU, S. T. (1995a). Calcium dependent K-channels in guinea pig and human urinary bladder. Biochemical and Biophysical Research Communications 213, 404-409.
117. 3H-P1075 binding in bladder smooth muscle. Pharmacology 50, 388-397.
118. TRUSS, M., STIEF, C. G., ÜCKERT, S., BECKER, A. J., FORSSMANN, W.-G. & JONAS, U. (1997). Initial clinical experience with the selective phosphodiesterase (PDE)-I isoenzyme-inhibitor vinpocitine in the treatment of urge-incontinence and low compliance bladder. Journal of Urology 157, 187 (abstract 727).
119. TRUSS, M., ÜCKERT, S., STIEF, C. G., FORSSMANN, W. G. & JONAS, U. (1996a). Cyclic-nucleotide phosphodiesterae (PDE) isoenzymes in the human detrusor smooth-muscle. II. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro. Urological Research 24, 129-134.
120. TRUSS, M., ÜCKERT, S., STIEF, C. G., KUCZYK, M. & JONAS, U (1996b). Cyclic nucleotide-phosphodiesterae (PDE) isoenzymes in the human detrusor smooth muscle. I. Identification and characterization. Urological Research 24, 123-128.
121. TRUSS, M., ÜCKERT, S., STIEF, C. G., KUCZYK, M., SCHULZ-KNAPPE, P., FORSSMANN, W.-G. & JONAS, U. (1996c). Effects of various phosphodiesterase-inhibitors, forskolin, and-sodium nitroprusside on porcine detrusor muscle tonic responses to muscarinic stimulation and cyclic nucleotide levels in vitro. Neurourology and Urodynamics 15, 59-70.
122. TRUSS, M., ÜCKERT, S., STIEF, C. G., KUCZYK, M., SCHULZ-KNAPPE, P., FORSSMANN, W.-G. &-JONAS, U. (1995). Porcine detrusor cyclic nucleotide phosphodiesterase isoenzyme: characterization and functional effects of various phosphodiesterase inhibitors in vitro. Urology 45, 893-901.
123. VANE, J. R. (1996). Mechanism of action of anti-inflammatory drugs. Scandinavian Journal of Rheumatology suppl 102, 9-21.
124. WALLIS, R. M., BURGES, R. A., CROSS, P. E., MACKENZIE, A. R., NEWGREEN, D. T. & QUINN, P. (1995). Darifenacin, a selective muscarinic M3 antagonist. Pharmacological Research 31, suppl., 54.
125. 1a-adrenoceptor in the rat, monkey and human urinary bladder and prostate. Journal of Urology 157, 1032-1038.
126. WANG, P., LUTHIN, G. R. & RUGGIERI, M. R. (1995). Muscarinic acetylcholine receptor-subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. Journal of Pharmacology and Experimental Therapeutics 273, 959-966.
127. WATSON, N., REDDY, H., STEFANICH, E. & EGLEN, R. M. (1995). Characterization of the interaction of zamifenacin at muscarinic receptors. European Journal of Pharmacology 285, 135-142.
128. WELLNER, M. C. & ISENBERG, G. (1993). Stretch-activated nonselective cation channels in urinary bladder myocytes: importance for pacemaker potentials and myogenic response. Experientia 66, 93-99.
129. WESSLER, I., KIRKPATRICK, C. J. & RACKE, K. (1998). Non-neuronal acetylcholine, locally-acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacology and Therapeutics 77, 59-79.
130. WEIN, A. J. (1995). Pharmacology of incontinence. Urological Clinics of North America 22, 557-577.
131. WHEELER, M. A., PONTARI, M., NISHIMOTO, T. & WEISS, R. M. (1990). Changes in lipid-composition and isoproterenol-and ethanol-stimulated adenylate cyclase activity in aging Fischer rat bladders. Journal of Pharmacology and Experimental Therapeutics 254, 277-283.
132. YAMAGUCHI, O., SHISDA, K., TAMURA, K., OGAWA, T., FUJIMURA, T. & OHTSUKA, M. (1996). Evaluation of mRNAs encoding muscarinic receptor subtypes in human detrusor muscle. Journal of Urology 156, 1208-1213.
133. YAMAMOTO, T., HONBO, T., TOKORO, K., KOJIMOTO, Y., KODAMA, R., OHTSUKA, M. & SHINOMURA, K. (1995a). General pharmacology of the new antimuscarinic compound vamicamide. Arzeimittelforschung 45, 1274-1284.
134. YAMAMOTO, T., KOIBUCHI, Y., MIURA, S., SAWADA, T., OZAKI, R., ESUMI, K. & OHTSUKA, M. (1995b). Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. Journal of Urology 154, 2174-2178.
135. YOKOYAMA, O., NAGANO, K., KAWAGUCHI, K. & HISAZUMI, H. (1991). The response of the detrusor muscle to acetylcholine in patients with infravesical obstruction. Urological Research 19, 117-121.
136. YU, Y. B., FRASER, M. O. & DE GROAT, W. C. (1996). Effect of intravesical administration of ZD6169 on the micturition reflex and on c-fos expression in the spinal cord induced by noxious bladder stimulation in the rat. Society for Neuroscience Abstracts 22, 93 (abstract 45.8).
137. ZAR, M. A., IRAVANI, M. M. & LUHESHI, G. N. (1990). Effect of nifedipinc on the contractile responses of the isolated rat bladder. Journal of Urology 143, 835-839.
138. ZENG, X.-P., MOORE, K. H. & BURCHER, E. (1995). Characterization of tachykinin NK-2 receptors in human urinary bladder. Journal of Urology 153, 1688-1692.